Relative to other vaccine developments, the creating of a Covid-19 vaccine has been incredibly rapid. Normally, vaccine development takes between five to ten years. While the vaccine development for Covid-19 has been short, efforts to create a Covid-19 vaccine were helped by earlier studies of similar diseases such as the severe acute respiratory syndrome (SARS) epidemic in 2002. The urgency of creating a Covid-19 vaccine led to a great deal of collaboration between governments and international pharmaceutical companies. Since Covid-19 was widespread, the clinical trial phases were combined and completed more rapidly than if the disease was rarer. As with all vaccines produced in the U.S., they must get approval from the Food and Drug Administration (FDA). The FDA granted Emergency Use Authorizations (EUA) for the Covid-19 vaccines meaning they can be distributed quickly while the FDA continues to monitor the safety of the vaccines.

The following links are for anyone looking to conduct research on the Covid-19 vaccine.